Trial intelligence / Profile preview

Advance Provision of Medication Abortion

NCT03829696Phase 4Withdrawn

Sponsor
University of California, San Francisco
Start
Jan 2020
Primary completion
Jan 2021
Modality
Orthosteric Ligands
01

Overview

A Phase 4 trial of mifepristone in unintended pregnancy, sponsored by University of California, San Francisco. Planned start Jan 2020; status: withdrawn.

02

Drugs

mifepristone
03

Conditions

unintended pregnancy

Beyond the preview

Go deeper on NCT03829696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03829696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call